GT Biopharma, Inc.
GT Biopharma entered an agreement with the University of Minnesota for a phase 1a/1b clinical trial of GTB-5550. The $3.8M research program will study the drug's use in advanced solid tumors over three years.
GT Biopharma, Inc. GTBP is headquartered in San Francisco, CA.
Posted Apr 7, 2026, 11:33 AM UTC
10